TENX vs VNO · P/E 3.4, $24.1M cap vs rev $921.3M
Tenax Therapeutics Inc (TENX) versus VNO (VNO) — a side-by-side from cached financials, not a winner call.
Tenax Therapeutics Inc (TENX) is a biotechnology company listed on US.
VNO (VNO) common stock.
Latest reported TENX revenue for 2026-06-30 was $0. Net income was -$33.5M. TENX currently screens at market cap $24.1M and trailing P/E 3.4.
Latest reported VNO revenue for 2026-06-30 was $921.3M. Net income was $24.6M. VNO currently screens at market cap $0.
TENX currently screens at market cap $24.1M and trailing P/E 3.4. VNO currently screens at market cap $0.
Not investment advice. Open the TENX and VNO stock pages for the full models.
Not investment advice.